SCHEMBL22401398

SCHEMBL22401398

CCC(CC)(CC(N)=O)c1ccc(OCCN2CCOCC2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.59
▸ GAA P10253 1/20 0.59
▸ ALDH1A1 P00352 8/20 0.55
▸ KDM4E B2RXH2 2/20 0.55
▸ CA12 O43570 1/20 0.52
▸ CA1 P00915 1/20 0.52
▸ CA2 P00918 1/20 0.52
▸ CA7 P43166 1/20 0.52
▸ CA9 Q16790 1/20 0.52
▸ LMNA P02545 3/20 0.52
▸ USP2 O75604 2/20 0.52
▸ TSHR P16473 1/20 0.52
▸ MAPK1 P28482 2/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CHRM2 P08172 1/20 0.51
▸ CHRM1 P11229 1/20 0.51
▸ HTR2A P28223 1/20 0.51
▸ SCN1A P35498 1/20 0.51
▸ HTR2B P41595 1/20 0.51
▸ KCNH2 Q12809 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22401399 0.82 KDM4E (0.48) ALDH1A1KDM4EHRH3KMT2AMEN1
SCHEMBL13930969 0.78 ALDH1A1 (0.62) SMN1; SMN2GAAALDH1A1KDM4ECA12
SCHEMBL13952296 0.78 HRH3 (0.67) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL5300447 0.77 ALDH1A1 (0.64) SMN1; SMN2GAAALDH1A1KDM4ECA12
SCHEMBL21049830 0.77 ALDH1A1 (0.63) SMN1; SMN2GAAALDH1A1KDM4ECA12
SCHEMBL9505607 0.77 ALDH1A1 (0.64) SMN1; SMN2GAAALDH1A1KDM4ECA12
SCHEMBL1395845 0.77 LTA4H (0.61) SMN1; SMN2GAAALDH1A1KDM4ECA12
SCHEMBL3007594 0.76 GAA (0.71) SMN1; SMN2GAAALDH1A1KDM4ECA12
SCHEMBL4404318 0.76 KDM4E (0.75) SMN1; SMN2GAAALDH1A1KDM4ECA12
Hydrochloric Acid SCHEMBL14742324 0.75 GAA (0.70) SMN1; SMN2GAAALDH1A1KDM4ECA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3707125-A1 CAFFEIC ACID DERIVATIVES FOR TREATING HYPERPROLIFERATIVE DISEASES Board Of Regents, The University Of Texas System (US) 2020-09-16 — — EP disclosed
Send feedback